Current clinical management strategies for benign prostatic hyperplasia
Zhang, X-Hua.
Chinese Medical Journal 121(17): 1759-1760
2008
ISSN/ISBN: 0366-6999 PMID: 19024115 Document Number: 619962
Document emailed within 1 workday
Related Documents
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Samkange, C.; Bhagat, K. 2000: Pharmacological management of benign prostatic hyperplasia Central African Journal of Medicine 46(8): 224-228
Biktimirov, R.G.; Martov, A.G.; Biktimirov, T.R.; Kaputovskij, A.A. 2019: The current status of surgical treatment of benign prostatic hyperplasia with volume over 80 Urologiia 3: 128-133
Fawzy, A. 2001: Current issues and reported findings from the National Survey on Benign Prostatic Hyperplasia International Journal of Clinical Practice. Supplement 2001(122): 2-22
Fitzpatrick, J.M.; Lynch, T.H. 1995: Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia Urologic Clinics of North America 22(2): 407-412
Suardi, N.; Gallina, A.; Salonia, A.; Briganti, A.; Cestari, A.; Guazzoni, G.; Rigatti, P.; Montorsi, F. 2009: Open prostatectomy and the evolution of HoLEP in the management of benign prostatic hyperplasia Minerva Urologica e Nefrologica 61(3): 301-308
Madsen, F.A.; Bruskewitz, R.C. 1995: Clinical manifestations of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 291-298
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Song, Y.; Li, N.-c.; Wang, X.-f.; Ma, L.-l.; Wan, B.; Hong, B.-f.; Na, Y.-q. 2005: Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia Zhonghua Nan Ke Xue 11(9): 674-676
Effert, P.; Ackermann, R. 1992: Clinical manifestations and indications for therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 31(3): 135-141
Wu, X.-j.; Yang, L.-y.; Zhang, X.-z. 2008: A clinical analysis of benign prostatic hyperplasia with chronic prostatitis Zhonghua Nan Ke Xue 14(6): 527-529
Sánchez Merino, Jé.María.; Parra Muntaner, L.; Gómez Cisneros, S.Carlos.; Monsalve Rodríguez, M.; Jiménez Rodríguez, M.; García Alonso, Jús. 2002: Implementation of a clinical pathway for transurethral resection in benign prostatic hyperplasia Archivos Espanoles de Urologia 55(2): 131-144
Bozdar, H.R.; Memon, S.R.; Paryani, J.P. 2010: Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia Journal of Ayub Medical College Abbottabad: Jamc 22(4): 194-196
Yajima, M.; Takemura, H.; Nishida, S.; Matsushita, T.; Yanagisawa, N.; Baba, K.; Iwamoto, T. 1999: Clinical study of transurethral electrovaporization of the prostate for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 45(9): 609-612
Nishimoto, K. 1990: Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 36(1): 19-26
Mazo, E.B.; Dmitriev, D.G. 2001: Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis Urologiia 5: 38-41
Tyuzikov, I.A.; Grekov, E.A.; Kalinchenko, S.Y. 2015: Features of Clinical Course and Morphometric Parameters of Benign Prostatic Hyperplasia in Men with Metabolic Syndrome and Androgen Deficiency Urologiia 5: 66-69
Sumiyoshi, T.; Kohno, J.; Maeno, A.; Okubo, K.; Takahashi, T.; Mitsumori, K.; Nishimura, K. 2016: Clinical Outcomes of Anteroposterior Dissection Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 62(9): 449-453
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216